The HCC patient samples in the TCGA database were divided into high and low expression groups of ATXN3, JOSD1, JOSD2, and the distribution of immune checkpoints in different gene expression samples was studied (Figure 10). This evidence concerns the gene JOSD2 and hepatocellular carcinoma.